semaglutide bowel issues Semaglutide-Induced Small Pseudo-Obstruction and Ileitis in a Patient With Type 2 Diabetes: A Case Report Weighing the Risks: Small Bowel

The choice between GLP-1 vs other weight loss methods ultimately depends on a thorough discussion with a healthcare provider, considering the patients health status, weight loss goals, and tolerance for risk

Vomiting Some individuals may vomit, often related to nausea

Any perceived benefits are likely minor and highly variable: Professional glutathione treatments, especially injections, are often seen as more potent for skin lightening

Meta-analyses of CVOTs such as LEADER, SUSTAIN-6, and REWIND further corroborate the stroke prevention benefits of GLP-1 receptor agonists, solidifying their position as a preferred option for ischemic stroke prevention in T2DM patients